Johnson & Johnson
(MEX:JNJ)
MXN
4,532
-28 (-0.61%)
Market Cap: 10.89 Tn
Enterprise Value: 11.36 Tn
PE Ratio: 30.95
PB Ratio: 7.57
GF Score: 69/100 Johnson & Johnson at Wells Fargo Healthcare Conference Transcript
Sep 09, 2026 / 03:00PM GMT
Release Date Price:
MXN4532
(-0.61%)
Lawrence Biegelsen
Wells Fargo Securities LLC - Analyst
Welcome back, and good morning. I'm Larry Biegelsen, the MedTech analyst at Wells Fargo. It's my pleasure to host the next fireside chat with the management team from Johnson & Johnson. With us, we have Tim Schmid, Executive Vice President and Worldwide Chairman, MedTech. It's, as I said, fireside chat.
Tim, thanks for being here again.
Tim Schmid
Johnson & Johnson - Executive Vice President, Worldwide Chairman of MedTech
My pleasure, Larry, and thank you for the opportunity to represent J&J.
Questions & Answers
Lawrence Biegelsen;Tim Schmid
Wells Fargo Securities LLC - Analyst;Johnson & Johnson - Executive Vice President,
So let's start with a couple of big-picture questions. At your last Investor Day, I think it was December 2023. You had a goal to grow at the high end of MedTech, which you pegged at 5% to 7%. How has the market perform relative to your expectations? And how are you doing?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot